Stock screenerAll disclosures →
EDGAR →
RARE
Conviction 61HealthcareScan · Thu, Jun 25, 2026Shooting star
RARE$29.25+0.48%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 2.04M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price29.25
Change+0.48%
Gap+0.74%
Rel volume1.38×
Avg volume1.96M
Avg $ vol49.4M
SMA 2024.79
SMA 5024.73
SMA 20026.98
Price vs 50+18.26%
Price vs 200+8.41%
MA stackmixed
50/200 cross—
Supertrendup · 25.76
RSI (14)71
MACD hist0.67
MACD crossbull · 9d
Stoch %K / %D86 / 89
ADX (14)33
+DI / −DI36 / 9
RSI divergence—
MACD divergence—
ATR %+4.47%
ADR %4.98%
52w high41.44
52w low18.50
From 52w high-29.42%
Above 52w low+58.11%
New 52w highNo
SqueezeOff
Bollinger width41.85%
%B0.93
Donchian pos85.71%
Donchian high30.57
Donchian low21.33
AVWAP (52w high)26.38
vs AVWAP high+10.88%
AVWAP (52w low)24.01
vs AVWAP low+21.84%
OBV trendUp
Chaikin MF (20)-0.07
Today vs 20d1.38×
Avg vol (14d)2.04M
Avg vol (20d)1.96M
Avg $ vol (20d)49.4M
Market cap2.88B
RS 3m (vs SPY)+45.09%
RS 6m (vs SPY)-20.84%
RS line new highYes
Trend template4/8
Technical rank63.5
1 week+8.70%
1 month+26.40%
3 months+47.36%
6 months-15.83%
1 year-21.29%
YTD+23.94%
P/E-5.01
P/B-12.21
P/S4.28
P/FCF-6.10
EPS-5.83
Div yield—
ROE243.64%
ROA-44.37%
Debt/Eq—
Current2.02
EV/EBITDA-5.41
Gross margin—
Net margin-85.44%
Rev growth20.18%
EPS growth-1.05%
Price target53.79
Target upside83.90%
Analyst ratingBuy
Institutional112.80%
Ent. value2.71B
Revenue136M
Net income-185M
Gross profit—
Free cash flow-472M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out98.49M
Employees1.37K
ListedFri, Jan 31, 2014
Free float91.5M
Float %94.9%
Short interest14.7M
Days to cover9.8d
Short volume37.2%
Squeeze score63 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast−$1.25 · 7 est
Last EPS vs est−$1.84 vs −$1.55
Last surprise-18.7% miss
Setup gradeB
Conviction61 / 100
Pattern quality—
Tech rank63.5 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmShooting star
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in RARE · 3 recent
Insider activity
SEC Form 4 transactions in RARE · 8 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Horn Howard Chief Financial Officer · Common Stock · 2026-06-01 | Sell | 4.65K | $111K | 2026-06-01 | 2026-06-01 |
SULIMAN SHEHNAAZ Director · Common Stock · 2026-05-18 | Sell | 5.74K | $144K | 2026-05-18 | 2026-05-18 |
WELCH DANIEL G Director · Common Stock · 2026-05-14 | Grant | 7.75K | $0 | 2026-05-14 | 2026-05-18 |
Dunsire Deborah Director · Common Stock · 2026-05-14 | Grant | 7.75K | $0 | 2026-05-14 | 2026-05-18 |
Sanders Corazon (Corsee) D. Director · Common Stock · 2026-05-14 | Grant | 7.75K | $0 | 2026-05-14 | 2026-05-18 |
Fust Matthew K Director · Stock Option (Right to Buy) · 2026-05-14 | Grant | 14.06K | $0 | 2026-05-14 | 2026-05-18 |
Ray Amrit Director · Common Stock · 2026-05-14 | Grant | 7.75K | $0 | 2026-05-14 | 2026-05-18 |
Fust Matthew K Director · Common Stock · 2026-05-14 | Grant | 7.75K | $0 | 2026-05-14 | 2026-05-18 |
WELCH DANIEL G Director · Stock Option (Right to Buy) · 2026-05-14 | Grant | 14.06K | $0 | 2026-05-14 | 2026-05-18 |
NARACHI MICHAEL Director · Common Stock · 2026-05-14 | Grant | 7.75K | $0 | 2026-05-14 | 2026-05-18 |
SEC filings
EDGAR filings in RARE · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.